High multiplexing capacity enables the detection of multiple analytes from crude, inhibitor-rich plasma, serum and whole blood samples
Lyo-Ready ™ Direct DNA qPCR Blood (MDX122)
S. aureus
P. falciparum
Epstein-Bar virus
Lyo-Ready ™ Direct DNA qPCR Blood | KAPA Probe Force | TaqPath ProAmp Mix
Three diagnostic DNA targets ( Staphylococcus aureus, Plasmodium falciparum and Epstein-Bar virus) were amplified in a triplex reaction using lyophilized Lyo-Ready ™ Direct DNA qPCR Blood (MDX122) ( red ), KAPA Probe Force ( green ) or TaqPath ProAmp Mix ( black ) in the presence of 10% EDTA plasma or 10% serum. The results illustrate that Lyo-Ready ™ Direct DNA qPCR Blood has higher multiplexing capacity and performance than Kapa Probe Force and TaqPath ProAmp Mix.
Lyo-Ready ™ Direct RNA/DNA qPCR Blood (MDX123)
Dengue
S. pneumoniae
Zika
Chikungunya
Lyo-Ready ™ Direct RNA/DNA qPCR Blood | TaqPath 1-Step Multiplex Master Mix | UltraPlex 1-Step ToughMix
Three viral RNA targets (Dengue, Zika and Chikungunya) and a DNA target ( S. pneumonia ) were amplified in a quadruplex reaction using lyophilized Lyo-Ready ™ Direct RNA/DNA qPCR Blood ( red ), TaqPath 1-Step Multiplex Master Mix ( black ) or UltraPlex 1-Step ToughMix ( grey ) in the presence of 5% EDTA blood or 5% K2-EDTA plasma. The results illustrate that Lyo-Ready ™ Direct RNA/DNA qPCR Blood has higher multiplexing capacity and performance than supplier TaqPath or UltraPlex.
www.MeridianLifeScience.com
Powered by FlippingBook